NCR3 and gastric cancer: In this context, the downregulation of the signaling protein CD3ζ was observed in PB-NK cells from GC patients and affected CD16-mediated responses to Herceptin (anti-HER2 mAbs) [116], but also possibly dampened surface expression and signaling through NKp46 and NKp30.